Drugs / Drug / Clinical / Boston / Boston blog main / Boston top stories / Indiana blog main / National blog main / New York blog main / Raleigh-Durham blog main / San Diego blog main / San Francisco blog main / Seattle blog main / ArrowMark Partners / Beta Bionics / BigFoot Biomedical / Biotech / Boston University / clinical trials / congenital hyperinsulinism / deals / DexCom / diabetes / Drug Delivery / Edward Damiano / Eli Lilly / Eventide Asset Management / FDA / insulinoma syndrome / investing / Life Sciences / LifeSci Venture Partners / Medical Device / medtech / Medtronic / Novo Nordisk / RoboticsAI / RTW Investments / Software / startups / Type 1 diabetes / VC / Venture Capital / Wearable Devices / Wearable Insulin Pump / Zealand Pharma

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Posted on: Jan 9, 2019   |   Posted by: Biotech Mag

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Beta Bionics, a startup developing a medical device that monitors and manages blood sugar levels in diabetes patients, has closed $63 million to back late-stage clinical tests...

Continue reading ...